Vericel (NASDAQ:VCEL) Given “Overweight” Rating at Stephens
Stephens reaffirmed their overweight rating on shares of Vericel (NASDAQ:VCEL – Free Report) in a research report sent to investors on Monday,Benzinga reports. They currently have a $67.00 target price on the biotechnology company’s stock. Several other analysts also recently weighed in on VCEL. Wall Street Zen downgraded Vericel from a “hold” rating to a […]
More Stories
State Department Launches Birth Tourism Prevention Task Force
By Troy Myers The Department of State on Wednesday announced the existence of a task force that has already revoked...
Todd Blanche Sworn In as Attorney General
By Kimberly Hayek Todd Blanche, President Donald Trump’s former personal lawyer, was sworn in Monday as U.S. attorney general and...
16,000 Arrests Made as Part of Operation to Make Washington Safe
By Naveen Athrappully More than 16,000 individuals have been arrested in Washington since the launch of the Make D.C. Safe...
Commercial Chapter 11 Bankruptcy Filings Decrease Annually
By Naveen Athrappully There were 666 commercial Chapter 11 bankruptcy filings made in the United States in July, a 27...
Syrian Court Sentences Ex-President Bashar Assad to Death
By Tom Ozimek A Syrian court sentenced ousted leader Bashar al-Assad to death on Tuesday, convicting him of crimes committed...
11 Charged in Immigration Scheme Involving Over 1,000 Sham Marriages
By Jackson Richman The Department of Justice (DOJ) has charged 11 people with allegedly helping foreign nationals, primarily Chinese nationals,...